Delhi NCR, India.
+91-8750295029
info@medvitaz.com
Join Now
0
Primary Menu
Home
Profile
About Us
Registered Pharmacist
Form GST REG-06
Importer-Exporter Code
Patient Testimonials
Services
2nd Opinion
For Breast Cancer
For Gastric Cancer
For Hepatitis C Virus
For Leukemia
For Lung Cancer
For Multiple Sclerosis
For Lymphoma
For Renal Cell Cancer
Anti Cancer Medicines
Breast Cancer
ENHERTU ® (fam-trastuzumab deruxtecan-nxki) for injection
IBRANCE (palbociclib) capsules
IXEMPRA Kit (ixabepilone) for Injection
KADCYLA (ado-trastuzumab emtansine) for injection
KISQALI (ribociclib) tablets
LYNPARZA (olaparib) tablets
ONTRUZANT (trastuzumab-dttb) for injection
Palbace (palbociclib) capsules
PERJETA ™ (pertuzumab) Injection
PHESGO (pertuzumab, trastuzumab, and hyaluronidase-zzxf) injection
PIQRAY (alpelisib) Tablets
TRODELVY (sacituzumab govitecan-hziy)
TUKYSA (tucatinib) tablets
Bladder
PADCEV (enfortumab vedotin-ejfv) for injection
TECENTRIQ (atezolizumab) injection
Colorectal
LONSURF (trifluridine and tipiracil) tablets
Head and Neck
Kidney
PARSABIV (etelcalcetide) injection
VOTRIENT (pazopanib) tablets
VORAXAZE (glucarpidase) For Injection
Liver
PEMAZYRE (pemigatinib) tablets
Lung Cancer
ESBRIET (pirfenidone) capsules
LUMAKRAS (sotorasib) tablets. Get Access In India
OPDIVO (nivolumab) injection
ROZLYTREK (entrectinib) capsules
SYNAGIS (palivizumab) injection
TABRECTA (capmatinib) tablets
TRIKAFTA Tablets
Other Medications
BYNFEZIA PEN (octreotide acetate)
MACRILEN (macimorelin)
INREBIC (fedratinib)
QUZYTTIR (cetirizine hydrochloride injection)
RAVICTI (glycerol phenylbutyrate)
REBLOZYL (luspatercept-aamt)
Soliris (eculizumab)
SYLVANT (siltuximab)
TEGSEDI (inotersen)
UNITUXIN (dinutuximab)
VISTOGARD (uridine triacetate)
VITRAKVI (larotrectinib)
Ovarian Cancer
AVASTIN (bevacizumab) Solution
ZEJULA (niraparib) capsules
Pancreatic Cancer
Prostate Cancer
ERLEADA (apalutamide) tablets
NUBEQA (darolutamide) tablets
XTANDI (enzalutamide) capsules. Get Access In India. Get Access In India
Stomach Cancer
AYVAKIT (avapritinib) tablets
CYRAMZA (ramucirumab) injection
ENTYVIO (vedolizumab) for injection, for intravenous use. Initial U.S. Approval: 2014. Get Access In India
QINLOCK (ripretinib) tablets
Thyroid Cancer
NUPLAZID (pimavanserin) tablets
TEPEZZA (teprotumumab-trbw) for injection
Blood Cancer
Lymphoma
ADCETRIS (brentuximab vedotin)
ALECENSA (Alectinib)
ALIQOPA (copanlisib)
BRUKINSA (zanubrutinib)
CALQUENCE (acalabrutinib)
IMBRUVICA (ibrutinib)
MONJUVI (tafasitamab-cxix)
POLIVY (polatuzumab vedotin-piiq)
Leukemia
BESPONSA (inotuzumab ozogamicin)
BLINCYTO (blinatumomab)
COPIKTRA (duvelisib)
GAZYVA (obinutuzumab)
ICLUSIG (ponatinib)
IDHIFA (enasidenib)
MYLOTARG (gemtuzumab ozogamicin)
ONUREG (azacitidine)
TIBSOVO (ivosidenib)
TREANDA (bendamustine hydrochloride)
VENCLEXTA (venetoclax)
XOSPATA (gilteritinib)
ZYDELIG (idelalisib)
Melanoma
COTELLIC (cobimetinib)
IMLYGIC (talimogene laherparepvec).
LIBTAYO (cemiplimab-rwlc)
MEKINIST (trametinib)
TAFINLAR (dabrafenib)
YERVOY (ipilimumab)
ZELBORAF (vemurafenib)
Multiple myeloma
BLENREP (belantamab mafodotin-blmf)
DARZALEX (daratumumab)
NINLARO (ixazomib)
POMALYST (pomalidomide)
REVLIMID [lenalidomide]
Others
ADAKVEO (crizanlizumab-tmca)
ANDEXXA (coagulation factor Xa (recombinant), inactivated-zhzo)
DANYELZA (naxitamab-gqgk)
INREBIC (fedratinib)
KALBITOR (ecallantide)
MULPLETA (lusutrombopag)
PROMACTA (eltrombopag)
Tasigna (nilotinib)
TAVALISSE ™ (fostamatinib disodium hexahydrate)
Medications
Brain
Bevacizumab Injection. Initial U.S. Approval: 2004
Arthritis
ACTEMRA (tocilizumab) injection
AVSOLA (infliximab-axxq) for injection
Asthma
NUCALA (mepolizumab) for injection
XOLAIR ® (omalizumab) for injection
Cardiovascular
Mexitil (mexiletine hydrochloride, USP) Capsules. Get Access In India
NEXLETOL (bempedoic acid) tablets. Get Access In India
VERQUVO (vericiguat) tablets. Get Access In India
COVID19
AVASTIN (bevacizumab)
Bevacizumab Injection
Remdac (remdesivir for injection)
ZycoRap SARS COV-2 Antigen Rapid Test. Get Access In India
eczema
DUPIXENT (dupilumab) injection
Eye
LUCENTIS (ranibizumab injection
EYLEA (aflibercept) Injection
Raxone (idebenone) tablets
HIV
BIKTARVY® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets
DARAPRIM (pyrimethamine) Tablets
INTELENCE 25 mg tablets
ISENTRESS (raltegravir) Film-Coated Tablets
ODEFSEY ® (emtricitabine, rilpivirine, and tenofovir alafenamide) tablets
PREZCOBIX (darunavir and cobicistat) tablet
PREZISTA (darunavir) Tablet
TIVICAY (dolutegravir) Tablets
TRIUMEQ (abacavir, dolutegravir, and lamivudine) tablets
TRUVADA® (emtricitabine/tenofovir disoproxil fumarate) tablets
Migraine
NURTEC ODT (rimegepant) tablets
Multiple Sclerosis
OCREVUS (ocrelizumab) injection
TYSABRI (natalizumab) injection
ZEPOSIA (ozanimod) capsules
Muscle
VILTEPSO (viltolarsen) injection. Get Access In India
Neurology
ONGENTYS (opicapone) capsules. Get Access In India
EXPAREL (bupivacaine liposome injectable suspension). Initial U.S. Approval: 1972. Get Access In India
Osteoporosis
ELAPRASE (idursulfase) injection. Get Access In India
OZURDEX (dexamethasone intravitreal implant). Get Access In India
EVENITY (romosozumab-aqqg) injection
YUTIQ (fluocinolone acetonide intravitreal implant). Get Access In India
Surgery
OMIDRIA (phenylephrine and ketorolac injection). Get Access In India
SOMATULINE DEPOT (lanreotide) injection. Get Access In India
VERQUVO (vericiguat) tablets. Get Access In India
Urinary
FETROJA (cefiderocol) for injection, for intravenous use. FDA Approved
Wrinkle
JEUVEAU (prabotulinumtoxinA-xvfs) for injection. Get Access In India
KLISYRI (tirbanibulin) ointment. Get Access In India
Awareness
News
Health Conferences
Global Summit on Cancer and Oncology Research
Contact
0
Cart
No products in the cart.
Leukemia
Home
Blood Cancer
Leukemia
Default sorting
Sort by popularity
Sort by latest
Sort by price: low to high
Sort by price: high to low
Show 12 On Page
Show 24 On Page
Show 48 On Page
Showing 1–12 of 14 results
BESPONSA (inotuzumab ozogamicin) for injection, for intravenous use. Initial U.S. Approval: 2017
BLINCYTO (blinatumomab) for injection, for intravenous use. Initial U.S. Approval: 2014
COPIKTRA (duvelisib), capsules for oral use. Initial U.S. Approval: 2018
GAZYVA (obinutuzumab) injection, for intravenous infusion. Initial U.S. Approval: 2013
ICLUSIG (ponatinib) tablets for oral use. Initial U.S. Approval: 2012
IDHIFA (enasidenib) tablets, for oral use. Initial U.S. Approval: 2017
MYLOTARG (gemtuzumab ozogamicin) for injection, for intravenous use. Initial U.S. Approval: 2000
ONUREG (azacitidine) tablets, for oral use. Initial U.S. Approval: 2004
Tasigna (nilotinib) Capsules Initial U.S. Approval: 2007
TIBSOVO (ivosidenib tablets), for oral use. Initial U.S. Approval: 2018
TREANDA (bendamustine hydrochloride) for Injection
VENCLEXTA (venetoclax) tablets, for oral use. Initial U.S. Approval: 2016
1
2
→